High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy

The purpose of the present study was to investigate whether expression levels of adenylate kinase 1 (AK1) were associated with prognosis of acute myeloid leukemia (AML) in patients treated with chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HSCT). 85 AML patients with AK1 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Tong, Zhao, Hongmian, Shao, Yunli, Hu, Ning, Shi, Jinlong, Fu, Lin, Zhang, Yijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300281/
https://www.ncbi.nlm.nih.gov/pubmed/32519744
http://dx.doi.org/10.1042/BSR20200097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300281/
https://www.ncbi.nlm.nih.gov/pubmed/32519744
http://dx.doi.org/10.1042/BSR20200097

Ejemplares similares